Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 74NC9 | — |
Wrong Solution Used (Dose mixed inadvertently with another diluent); was inadvertently given to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) (batch number 74NC9, expiry date 13-NOV-2026) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Wrong Solution Used (Dose mixed inadvertently with another diluent)) and inappropriate dose of vaccine administered (Verbatim: was inadvertently given to a patient). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 19-MAY-2025 Nurse calls to ask about the efficacy of the Shingrix dose that was inadvertently given to a patient. The nurse mixed a Shingrix vaccine with a regular diluent (non-specified from the Registered Nurse´s end). Vaccine detail was obtained in this call. The reporter consented to follow up. The vaccine administration facility was the same as primary reporter.